InvestSMART

Orthocell Limited (ASX: OCC) - Announcements

Current share price for OCC : $0.515 0.01 (1.90%)+

ASX company news and announcements for Orthocell Limited (OCC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orthocell Limited (OCC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orthocell Limited (OCC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orthocell Limited (OCC)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$140 Ceasing to be a substantial holder 10 Sep 2019 5:56PM $0.385 $0.515 risen by 33.77%
$140 OCC presents at H.C. Wainwright Annual Investment Conference 10 Sep 2019 9:34AM $0.395 $0.515 risen by 30.38%
$140 Successful CelGro Tendon Regeneration Trial 4 Sep 2019 9:19AM $0.395 $0.515 risen by 30.38%
$140 Appendix 4G 30 Aug 2019 2:49PM $0.420 $0.515 risen by 22.62%
$140 Appendix 4E and Annual Report to Shareholders 30 Aug 2019 2:48PM $0.420 $0.515 risen by 22.62%
$140 Final Director's Interest Notice MC 26 Aug 2019 12:24PM $0.410 $0.515 risen by 25.61%
$140 Change of Management of OCC Shareholding 26 Aug 2019 11:22AM $0.415 $0.515 risen by 24.10%
$140 Ceasing to be a substantial holder 26 Aug 2019 11:20AM $0.415 $0.515 risen by 24.10%
$140 Ceasing to be a substantial holder 26 Aug 2019 11:18AM $0.415 $0.515 risen by 24.10%
$140 Change of Director's Interest Notice MC 26 Aug 2019 11:17AM $0.415 $0.515 risen by 24.10%
$140 Director Temporary Leave of Absence 23 Aug 2019 8:17AM $0.402 $0.515 risen by 28.11%
$140 Change of Director's Interest Notice QXZ 23 Aug 2019 8:13AM $0.402 $0.515 risen by 28.11%
$140 New Patent for CelGro Platform Technology 22 Aug 2019 8:04AM $0.395 $0.515 risen by 30.38%
$140 Appendix 3B and Notice Under Section 708A 14 Aug 2019 7:30PM $0.415 $0.515 risen by 24.10%
$140 Appendix 4C - Quarterly 31 Jul 2019 6:14PM $0.435 $0.515 risen by 18.39%
$140 Appendix 3B and Notice Under Section 708A 25 Jul 2019 7:22PM $0.490 $0.515 risen by 5.10%
$140 CelGro Study Validates High Quality Nerve Repair 25 Jul 2019 9:56AM $0.450 $0.515 risen by 14.44%
$140 Change of Director's Interest Notice * 4 11 Jul 2019 6:41PM $0.475 $0.515 risen by 8.42%
$140 Appendix 3B and Notice Under Section 708A 11 Jul 2019 6:27PM $0.475 $0.515 risen by 8.42%
$140 Appendix 3B and Notice Under Section 708A 1 Jul 2019 8:26AM $0.510 $0.515 risen by 0.98%
$140 CelGro Accelerates Dental Implant Treatments 19 Jun 2019 9:33AM $0.490 $0.515 risen by 5.10%
$140 Appendix 3B 13 Jun 2019 7:29PM $0.425 $0.515 risen by 21.18%
$140 Change in substantial holding MHZ 11 Jun 2019 8:34AM $0.405 $0.515 risen by 27.16%
$140 Change in substantial holding SRV 7 Jun 2019 12:55PM $0.410 $0.515 risen by 25.61%
$140 Change in substantial holding MC 7 Jun 2019 12:55PM $0.410 $0.515 risen by 25.61%

501 - 525 of 775 results

Page 21 of 31

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.